Kangmei Pharmaceutical Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$3,117
Revenue Growth (%)19.79%
Net Income (US$ Millions)$481
Earnings Per Share (US$)$0.10
EPS Growth Rate (%)6.90%
Profit Margin15.43%
Total Equity (US$ Millions)$4,193
Return on Equity (%)17.80%
Long Term Debt (US$ Millions)$704
Debt To Equity Ratio (%)0.17%
Total Assets (US$ Millions)$7,895
Current Assets (US$ Millions)$6,403
Current Liabilities (US$ Millions)$2,884
Cost of Goods Sold (US$ Millions)$2,185
Inventory Turnover1.35